TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 11, Pages 2525-2530
Publisher
Oxford University Press (OUP)
Online
2013-07-10
DOI
10.1093/carcin/bgt244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
- (2012) Christian Körner et al. BMC CANCER
- miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver
- (2012) Koji Okamoto et al. EMBO JOURNAL
- A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non–Small-Cell Lung Cancer
- (2012) Xiaomin Niu et al. Journal of Thoracic Oncology
- Interleukin-10 Haplotype May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer
- (2012) Yaw-Cheng Wang et al. PLoS One
- TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
- (2011) Xiaoxiang Guan et al. BMC CANCER
- Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians
- (2011) R.D. Mittal et al. EJSO
- Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells
- (2011) Ling Su et al. EUROPEAN JOURNAL OF CANCER
- Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers
- (2011) Michelle G. Dick et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2011) Xifeng Wu et al. JNCI-Journal of the National Cancer Institute
- Paclitaxel Induces Apoptosis Through Activation of Nuclear Protein Kinase C-δ and Subsequent Activation of Golgi Associated Cdk1 in Human Hormone Refractory Prostate Cancer
- (2011) Pin-Hsuan Lu et al. JOURNAL OF UROLOGY
- Epidemiology of Lung Cancer
- (2011) Aoife McErlean et al. SEMINARS IN ROENTGENOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Polymorphisms in Apoptosis-Related Genes and Survival of Patients with Early-Stage Non-Small-Cell Lung Cancer
- (2010) Eung Bae Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Evolutionary evidence of the effect of rare variants on disease etiology
- (2010) IP Gorlov et al. CLINICAL GENETICS
- Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis
- (2010) Linlang Guo et al. EUROPEAN JOURNAL OF CANCER
- Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo
- (2010) M. Nagane et al. NEURO-ONCOLOGY
- Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer
- (2010) Michelle A. T. Hildebrandt et al. PLoS One
- Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients
- (2009) C. C. Reyes-Gibby et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
- (2009) Bo Chen et al. EUROPEAN JOURNAL OF CANCER
- SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
- (2009) Zongli Xu et al. NUCLEIC ACIDS RESEARCH
- Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy
- (2008) Katharina Leithner et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now